Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29670758 | 1.00 | PTGS2 (0.50) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL28373276 | 0.98 | PTGS2 (0.49) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL11824904 | 0.83 | PTGS2 (0.48) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL2739332 | 0.82 | PTGS2 (0.74) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL11821456 | 0.82 | PTGS2 (0.74) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL4734664 | 0.81 | CYP17A1 (0.39) | PTGS2OPRK1PDE4DHPGDKMT2A | |
| SCHEMBL1345773 | 0.78 | MEN1 (0.38) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL31195717 | 0.77 | NOX1 (0.46) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL11824485 | 0.77 | PTGS2 (0.43) | PTGS2OPRK1PDE4DALDH1A1HPGD | |
| SCHEMBL3850258 | 0.77 | ALDH1A1 (0.53) | PTGS2OPRK1PDE4DALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108753185-A | High reliability TP with OCA optical adhesive tapes with and preparation method thereof | 苏州凡赛特材料科技有限公司 | 2018-11-06 | — | — | CN | claimed |
| WO-2018189516-A1 | FORCE SENSITIVE RESISTOR UV INK | RAINBOW TECHNOLOGY SYSTEMS LIMITED (GB) | 2018-10-18 | — | — | WO | claimed |
| CN-108441135-A | A kind of UV visbreakings composition, UV visbreaking films and preparation method thereof | 苏州城邦达力材料科技有限公司 | 2018-08-24 | — | — | CN | claimed |
| CN-108314933-A | A kind of the nano-silver thread conductive ink and its preparation method of high durable | 合肥微晶材料科技有限公司 | 2018-07-24 | — | — | CN | claimed |
| CN-108300336-A | A kind of UV visbreakings composition, UV visbreaking films and preparation method thereof | 苏州城邦达力材料科技有限公司 | 2018-07-20 | — | — | CN | claimed |
| CN-108276923-A | A kind of UV visbreakings composition, UV visbreaking films and preparation method thereof | 苏州城邦达力材料科技有限公司 | 2018-07-13 | — | — | CN | claimed |
| CN-108192415-A | A kind of photosensitive aqueous PCB route protections ink of UV and preparation method thereof | 东莞智炜新材料股份有限公司 | 2018-06-22 | — | — | CN | claimed |
| EP-3200754-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2017-08-09 | — | — | EP | claimed |
| CN-106835730-A | A kind of method that utilization UV-curing technology improves photon crystal structure color fastness on textile | 浙江理工大学 | 2017-06-13 | — | — | CN | claimed |
| CN-106687863-A | Passivation layer comprising a photocrosslinked fluoropolymer | 科慕埃弗西有限公司 | 2017-05-17 | — | — | CN | claimed |
| WO-2016050793-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2016-04-07 | — | — | WO | claimed |
| EP-4735529-A1 | CURABLE SILICONE COMPOSITION AND CURED PRODUCT THEREOF | Dow Silicones Corporation (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260085194-A1 | OPTICAL PRODUCT | TOKYO OHKA KOGYO CO LTD (JP) | 2026-03-26 | — | — | US | disclosed |
| US-12559628-B2 | Curable silicone composition and cured product thereof | DOW SILICONES CORPORATION (US) | 2026-02-24 | — | — | US | disclosed |
| US-12523930-B2 | Nanoimprint composition and pattern forming method | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| WO-2001007506-A2 | MICROFABRICATED DEVICES AND METHOD OF MANUFACTURING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2001-02-01 | — | — | WO | disclosed |
| US-H1299-H | Developing negative photoresist with acid in solubilizing solvent | PPG INDUSTRIES, INC. (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0095587-B1 | DENTAL COMPOSITE AND PORCELAIN REPAIR | DEN-MAT CORPORATION (US) | 1989-12-20 | — | — | EP | disclosed |
| EP-0138754-B1 | PHOTOCURABLE COMPOSITIONS | CIBA-GEIGY AG (CH) | 1988-05-25 | — | — | EP | disclosed |
| EP-0146501-B1 | POLYMERIZABLE COMPOSITIONS | CIBA-GEIGY AG (CH) | 1988-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559628-B2 | Curable silicone composition and cured product thereof | SMC2, ITGB1, ITGA1 | PTGS2 2124/4885OPRK1 2462/4885PDE4D 4875/4885 |
| US-20260085194-A1 | OPTICAL PRODUCT | PFN1, CFL1, C9 | PTGS2 2841/4885OPRK1 2014/4885PDE4D 4637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.